Identification of a natural soluble form of human CD5

Tissue Antigens

Volumn 54, Issue 2, 1999, Pages 128-137

  Calvo, J ^a   Places, L ^a   Espinosa, G ^b   Padilla, O ^a   Vila J M ^a   Villamor, N ^a   Ingelmo, M ^b   Gallart, T ^a   Vives, J ^a   Font, J ^b   Lozano, Francisco ^a,b  

^a INST D INVESTIGACIONS B   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

Circulating CD5; Soluble receptor; SRCR family

Indexed keywords

CD3 ANTIGEN; CD5 ANTIGEN; CD6 ANTIGEN; CYSTEINE; GLYCOPROTEIN; PHORBOL ESTER; SCAVENGER RECEPTOR; SECRETORY PROTEIN;

ANIMAL CELL; ANTIGEN ANTIBODY REACTION; ARTICLE; AUTOIMMUNE DISEASE; B CELL LEUKEMIA; CELL ACTIVATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNE SYSTEM; KIDNEY FAILURE; MOLECULAR WEIGHT; MONONUCLEAR CELL; MOUSE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN GLYCOSYLATION; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; SOLUBILITY; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; ANTIGENS, CD5; BLOTTING, WESTERN; CELLS, CULTURED; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MICE; RECOMBINANT PROTEINS; SOLUBILITY;

ANIMALIA;

EID: 0032878488     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0039.1999.540203.x     Document Type: Article

References (43)

1. Hardy RR, Hayakawa K. Development and physiology of LY-1 B and its human homolog, Leu-1 B. Immunol Rev 1986: 93: 53-79.
2. Ledbetter JA, Martin PJ, Spooner CE et al. Antibodies to Tp67 and Tp44 augment and sustain proliferative responses of activated T cells. J Immunol 1985: 135: 2331-6.
3. Tarakhovsky A, Kanner SB, Hombach J et al. A role for CD5 in TCR-mediated signal transduction and thymocyte selection. Science 1995: 269: 535-7.
4. Bikah G, Lynd FM, Aruffo AA, Ledbetter JA, Bondada S. A role for CD5 in cognate interactions between T cells and B cells, and identification of a novel ligand for CD5. Int Immunol 1998: 10: 1185-96.
5. Beyers AD, Spruyt LL, Williams AF. Molecular associations between the T-lymphocyte antigen receptor complex and the surface antigens CD2, CD4, or CD8 and CD5. Proc Natl Acad Sci U S A 1992: 89: 2945-9.
6. Lankester AC, van Schijndel GMW, Cordell JL, van Noesel CJM, van Lier RAW. CD5 is associated with the human B cell antigen receptor complex. Eur J Immunol 1994: 24: 812-6.
7. Imboden JB, June CH, McCutcheon MA, Ledbetter JA. Stimulation of CD5 enhances signal transduction by the T cell antigen receptor. J Clin Invest 1990: 85: 130-43.
8. 2+/Calmodulin-dependent kinase type IV is involved in the CD5-mediated signalling pathway in human T lymphocytes. J Biol Chem 1997: 272: 31809-20.
9. Gringhuis SI, de Leij LFMH, Coffer PJ, Vellenga E. Signaling through CD5 activates a pathway involving phosphatidylinositol 3-kinase, Vav and Rac1 in human mature T lymphocytes. Mol Cell Biol 1998: 18: 1725-35.
10. Calvo J, Vila JM, Places L et al. Human CD5 signalling and constitutive phosphorylation of C-terminal serine residues by casein kinase II. J Immunol 1998: 161: 6022-9.
11. Spertini F, Stohl W, Ramesh N, Moody C, Geha RS. Induction of human T cell proliferation by a monoclonal antibody to CD5. J Immunol 1991: 146: 47-52.
12. Alberola-Ila J, Places L, Cantrell DA, Vives J, Lozano F. Intracellular events involved in CD5-induced human T cell activation and proliferation. J Immunol 1992: 148: 1287-93.
13. Vandenberghe P, Ceuppens JL. Immobilised anti-CD5 together with prolonged activation of protein kinase C induce interleukin 2-dependent T cell growth: evidence for signal transduction through CD5. Eur J Immunol 1991: 21: 251-9.
14. Ceuppens JL, Baroja ML. Monoclonal antibodies to the CD5 antigen can provide the necessary second signal for activation of isolated resting T cells by solid-phase-bound OKT3. J Immunol 1986: 137: 1816-21.
15. Verwilghen J, Vandengerhe P, Wallays G et al. Simultaneous ligation of CD5 and CD28 on resting T lymphocytes induces T cell activation in the absence of T cell receptor/CD3 occupancy. J Immunol 1993: 150: 835-46.
16. Bikah G, Carey J, Ciallella JR, Tarakhovsky A, Bondada S. CD5-mediated negative regulation of antigen receptor-induced growth signals in B-1 B cells. Science 1996: 274: 1906-9.
17. Resnick D, Pearson A, Krieger M. The SRCR superfamily: a family reminiscent of the Ig superfamily. TIBS 1994: 19: 5-8.
18. Aruffo A, Bowen MA, Patel DD et al. CD6-ligand interactions: a paradigm for SRCR domain function? Immunol Today 1997: 18: 498-504.
19. Bowen MA, Whitney GS, Neubauer M et al. Structure and chromosomal location of the human CD6 gene. Detection of five human CD6 isoforms. J Immunol 1997: 158: 1149-56.
20. Patel DD, Wee SF, Whichard LP et al. Identification and characterisation of a 100-kDa ligand for CD6 on human thymic epithelial cells. J Exp Med 1995: 181: 1563-8.
21. Bowen MA, Patel DD, Li X et al. Cloning, mapping, and characterisation of activated leukocyte-cell adhesion molecule (ALCAM), a CD6 ligand. J Exp Med 1995: 181: 2213-20.
22. Van de Velde II, von Hoegen I, Luo W, Parnes JR, Thielemans K. The B-cell surface protein CD72/Lyb-2 is the ligand for CD5. Nature 1991: 351: 662-5.
23. Pospisil R, Fitts MG, Mage RG. CD5 is a potential selecting ligand for B cell surface immunoglobulin framework region sequences. J Exp Med 1996: 184: 1279-84.
24. Gebe JA. Kiener PA, Ring HZ, Li X, Francke U, Aruffo A. Molecular cloning, mapping to human chromosome 1 q21-q23, and cell binding characteristics of Spα, a new member of the Scavenger Receptor Cysteine-rich (SRCR) family of proteins. J Biol Chem 1997: 272: 6151-8.
25. Ehlers RW, Riordan JF. Membrane proteins with soluble counterparts: role of proteolysis in the release of transmembrane proteins. Biochemistry 1991: 30: 10065-74.
26. Bazil V. Physiological enzymatic cleavage of leukocyte membrane molecules. Immunol Today 1995: 16: 135-40.
27. Schleiffenbaum B, Spertini O, Tedder TF. Soluble L-selectin is present in human plasma at high levels and retains functional activity. J Cell Biol 1992: 119: 229-38.
28. Jones NH, Clabby ML, Dialynas DP, Huang HJS, Herzenberg LA, Strominger JL. Isolation of complementary DNA clones encoding the human lymphocyte glycoprotein T1/Leu-1. Nature 1986: 323: 346-9.
29. Gunning P, Leavitt J, Muscat G, Ng S, Kedes L. A human β-actin expression vector system directs high-level accumulation of antisense transcripts. Proc Natl Acad Sci U S A 1987: 84: 4831-5.
30. Simarro M, Pelassy C, Calvo J, Places L, Aussel C, Lozano F. The cytoplasmic domain of CD5 mediates both TCR/CD3-dependent and -independent diacylglycerol production. J Immunol 1997: 159: 4307-15.
31. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982: 25: 1271-7.
32. Vitali C, Bombardieri S, Moutsopoulos HM. Preliminary criteria for the classification of Sjögren's syndrome. Arthritis Rheum 1993: 36: 340-7.
33. International Workshop on Chronic Lymphocytic Leukemia. Recommendations for diagnosis, staging, and response criteria. Ann Intern Med 1989: 110: 236-8.
34. Lozano F, Calvo J, Roca A, Places L, Simarro M. CD5 cluster report. In: Kishimoto T, Kikutani H, von dem Borne AEGK et al., eds. Leukocyte Typing VI. White cells differentiation antigens. New York: Garland Publishing, Inc., 1998: 56-8.
35. Pino-Otin MR, Vinas O, de la Fuente MA et al. Existence of a soluble form of CD50 (Intercellular Adhesion Molecule-3) produced upon human lymphocyte activation. J Immunol 1995: 154: 3015-24.
36. Lozano F, Alberola-Ila J, Places L, Gallart T, Vives J. Protein kinase C-dependent up-regulation of CD5 surface expression on normal and lymphoblastoid T cells. Immunology 1990: 70: 434-9.
37. Law SKA, Micklem KJ, Shaw JM, Zhang X, Dong Y, Willis AC, Mason DY. A new macrophage differentiation antigen which is a member of the scavenger receptor superfamily. Eur J Immunol 1993: 23: 2320-5.
38. Jamin C, Magadur G, Lamour A et al. Cell-free CD5 in patients with rheumatic diseases. Immunol Letters 1991: 31: 79-84.
39. Noh GW, Lee KY. Circulating soluble CD5 in atopic dermatitis. Mol Cells 1998: 8: 618-22.
40. Massagué J, Pandiella A. Membrane-anchored growth factors. Annu Rev Biochem 1993: 62: 515-39.
41. Müllberg J, Oberthür W, Lottspeich F et al. The soluble human IL-6 receptor. Mutational characterisation of the proteolytic cleavage site. J Immunol 1994: 152: 4958-68.
42. Aicher B, Lerch MM, Müller T, Schilling J, Ullrich A. Cellular redistribution of protein tyrosine phosphatases LAR and PTPs by inducible proteolytic processing. J Cell Biol 1997: 138: 681-96.
43. Calvo J, Places L, Padilla O, Vilà JM, Vives J, Bowen MA, Lozano F. Interaction of recombinant and natural soluble CD5 forms with an alternative cell surface ligand. Eur J Immunol 1999: 29: in press.